Semin intervent Radiol 2023; 40(05): 467-471
DOI: 10.1055/s-0043-1772815
Abheek Ghosh
1
Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, Maryland
,
Sean Lee
2
Touro College of Osteopathic Medicine, New York City, New York
,
Christina Lim
3
Creighton University School of Medicine, Omaha, Nebraska
,
Robert L. Vogelzang
4
Division of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, Illinois
,
Howard B. Chrisman
4
Division of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, Illinois
› Author Affiliations
› Further Information
Also available at
![SFX Search]()
Buy Article Permissions and Reprints
Placenta accreta spectrum (PAS) is a clinical condition generally defined by the invasion of placental tissue into the wall of the uterus. More specifically, PAS refers to placenta accreta, placenta increta, and placenta percreta, which encapsulates a range of pathologic adherence of the placenta to the myometrial wall based on the depth of trophoblast penetration. Placenta accreta is the most common and least invasive form of PAS, while placenta percreta is the least common yet most invasive subtype ([Fig. 1]).[1] During delivery, PAS carries a significant risk for life-threatening hemorrhage and is associated with increased rates of maternal morbidity and mortality. Although modern imaging modalities such as ultrasound and magnetic resonance imaging (MRI) have provided valuable avenues to guide preoperative delivery planning, cesarean hysterectomy, the current gold-standard technique for PAS, does not allow patients the chance to preserve fertility.[2] With the ever-so-increasing rates of PAS in pregnancies over the last decade, it is imperative for physicians to strategize alternative treatment and prophylactic options for these patients that not only maximize clinical outcomes but also preserve fecundity.[3]
Fig. 1 Placenta accreta spectrum (PAS) refers to a range of pathologic adherence of the placenta to the myometrial wall of the uterus. Among the three categories of PAS depicted, placenta accreta is the least invasive yet most common subtype, being responsible for 75–78% of all PAS cases.Publication History
Article published online:
02 November 2023
© 2023. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
References
1
Jha P,
Pōder L,
Bourgioti C.
et al.
Society of Abdominal Radiology (SAR) and European Society of Urogenital Radiology (ESUR) joint consensus statement for MR imaging of placenta accreta spectrum disorders. Eur Radiol 2020; 30 (05) 2604-2615
2
American College of Obstetricians and Gynecologists,
Society for Maternal-Fetal Medicine.
Obstetric care consensus no. 7: placenta accreta spectrum. Obstet Gynecol 2018; 132 (06) e259-e275
3
Silver RM,
Barbour KD.
Placenta accreta spectrum: accreta, increta, and percreta. Obstet Gynecol Clin North Am 2015; 42: 381-402
4
Marshall NE,
Fu R,
Guise JM.
Impact of multiple cesarean deliveries on maternal morbidity: a systematic review. Am J Obstet Gynecol 2011; 205 (03) 262.e1-262.e8
5
Jauniaux E,
Collins S,
Burton GJ.
Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol 2018; 218 (01) 75-87
6
Fox KA,
Shamshirsaz AA,
Carusi D.
et al.
Conservative management of morbidly adherent placenta: expert review. Am J Obstet Gynecol 2015; 213 (06) 755-760
7
Perez-Delboy A,
Wright JD.
Surgical management of placenta accreta: to leave or remove the placenta?. BJOG 2014; 121 (02) 163-169 , discussion 169–170
8
Sentilhes L,
Ambroselli C,
Kayem G.
et al.
Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol 2010; 115 (03) 526-534
9
Pather S,
Strockyj S,
Richards A,
Campbell N,
de Vries B,
Ogle R.
Maternal outcome after conservative management of placenta percreta at caesarean section: a report of three cases and a review of the literature. Aust N Z J Obstet Gynaecol 2014; 54 (01) 84-87
10
Popovic M,
Puchner S,
Berzaczy D,
Lammer J,
Bucek RA.
Uterine artery embolization for the treatment of adenomyosis: a review. J Vasc Interv Radiol 2011; 22 (07) 901-909 , quiz 909
11
Soyer P,
Barat M,
Loffroy R.
et al.
The role of interventional radiology in the management of abnormally invasive placenta: a systematic review of current evidences. Quant Imaging Med Surg 2020; 10 (06) 1370-1391
12 LD., B., Leiomyomas. General Gynecology: The Requisites in Obstetrics and Gynecology. 2007: 459-480
13
Ravina JH,
Herbreteau D,
Ciraru-Vigneron N.
et al.
Arterial embolisation to treat uterine myomata. Lancet 1995; 346 (8976) 671-672
14
de Bruijn AM,
Ankum WM,
Reekers JA.
et al.
Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial. Am J Obstet Gynecol 2016; 215 (06) 745.e1-745.e12
15
Aoki M,
Tokue H,
Miyazaki M,
Shibuya K,
Hirasawa S,
Oshima K.
Primary postpartum hemorrhage: outcome of uterine artery embolization. Br J Radiol 2018; 91 (1087) 20180132
16
Kohi MP,
Spies JB.
Updates on uterine artery embolization. Semin Intervent Radiol 2018; 35 (01) 48-55
17
Resnick NJ,
Kim E,
Patel RS,
Lookstein RA,
Nowakowski FS,
Fischman AM.
Uterine artery embolization using a transradial approach: initial experience and technique. J Vasc Interv Radiol 2014; 25 (03) 443-447
18
Noel-Lamy M,
Tan KT,
Simons ME,
Sniderman KW,
Mironov O,
Rajan DK.
Intraarterial lidocaine for pain control in uterine artery embolization: a prospective, randomized study. J Vasc Interv Radiol 2017; 28 (01) 16-22
19
Wong S,
Ray Jr CE.
Adenomyosis - an overview. Semin Intervent Radiol 2022; 39 (01) 119-122
20
Morel O,
Malartic C,
Muhlstein J.
et al.
Pelvic arterial ligations for severe post-partum hemorrhage. Indications and techniques. J Visc Surg 2011; 148 (02) e95-e102
21
Fargeaudou Y,
Morel O,
Soyer P.
et al.
Persistent postpartum haemorrhage after failed arterial ligation: value of pelvic embolisation. Eur Radiol 2010; 20 (07) 1777-1785
22
Soyer P,
Morel O,
Fargeaudou Y.
et al.
Value of pelvic embolization in the management of severe postpartum hemorrhage due to placenta accreta, increta or percreta. Eur J Radiol 2011; 80 (03) 729-735
23
Soyer P,
Dohan A,
Dautry R.
et al.
Transcatheter arterial embolization for postpartum hemorrhage: indications, technique, results, and complications. Cardiovasc Intervent Radiol 2015; 38 (05) 1068-1081
24
Hwang SM,
Jeon GS,
Kim MD,
Kim SH,
Lee JT,
Choi MJ.
Transcatheter arterial embolisation for the management of obstetric haemorrhage associated with placental abnormality in 40 cases. Eur Radiol 2013; 23 (03) 766-773
25
Mei J,
Wang Y,
Zou B.
et al.
Systematic review of uterus-preserving treatment modalities for abnormally invasive placenta. J Obstet Gynaecol 2015; 35 (08) 777-782
26
Hequet D,
Morel O,
Soyer P,
Gayat E,
Malartic C,
Barranger E.
Delayed hysteroscopic resection of retained tissues and uterine conservation after conservative treatment for placenta accreta. Aust N Z J Obstet Gynaecol 2013; 53 (06) 580-583
27
Alanis M,
Hurst BS,
Marshburn PB,
Matthews ML.
Conservative management of placenta increta with selective arterial embolization preserves future fertility and results in a favorable outcome in subsequent pregnancies. Fertil Steril 2006; 86 (05) 1514.e3-1514.e7
28
Jung HN,
Shin SW,
Choi SJ.
et al.
Uterine artery embolization for emergent management of postpartum hemorrhage associated with placenta accreta. Acta Radiol 2011; 52 (06) 638-642
29
Wang Z,
Li X,
Pan J.
et al.
Uterine artery embolization for management of primary postpartum hemorrhage associated with placenta accreta. Chin Med Sci J 2016; 31 (04) 228-232
30
Soyer P,
Sirol M,
Fargeaudou Y.
et al.
Placental vascularity and resorption delay after conservative management of invasive placenta: MR imaging evaluation. Eur Radiol 2013; 23 (01) 262-271
31
Wei X,
Zhang J,
Chu Q.
et al.
Prophylactic abdominal aorta balloon occlusion during caesarean section: a retrospective case series. Int J Obstet Anesth 2016; 27: 3-8
32
Izbizky G,
Meller C,
Grasso M.
et al.
Feasibility and safety of prophylactic uterine artery catheterization and embolization in the management of placenta accreta. J Vasc Interv Radiol 2015; 26 (02) 162-169 , quiz 170
33
Pan Y,
Zhou X,
Yang Z,
Cui S,
De W,
Sun L.
Retrospective cohort study of prophylactic intraoperative uterine artery embolization for abnormally invasive placenta. Int J Gynaecol Obstet 2017; 137 (01) 45-50
34
Cali G,
Forlani F,
Giambanco L.
et al.
Prophylactic use of intravascular balloon catheters in women with placenta accreta, increta and percreta. Eur J Obstet Gynecol Reprod Biol 2014; 179: 36-41
35
Bodner LJ,
Nosher JL,
Gribbin C,
Siegel RL,
Beale S,
Scorza W.
Balloon-assisted occlusion of the internal iliac arteries in patients with placenta accreta/percreta. Cardiovasc Intervent Radiol 2006; 29 (03) 354-361
36
Sewell MF,
Rosenblum D,
Ehrenberg H.
Arterial embolus during common iliac balloon catheterization at cesarean hysterectomy. Obstet Gynecol 2006; 108 (3, Pt 2): 746-748
37
Shrivastava V,
Nageotte M,
Major C,
Haydon M,
Wing D.
Case-control comparison of cesarean hysterectomy with and without prophylactic placement of intravascular balloon catheters for placenta accreta. Am J Obstet Gynecol 2007; 197 (04) 402.e1-402.e5
38
Duan XH,
Wang YL,
Han XW.
et al.
Caesarean section combined with temporary aortic balloon occlusion followed by uterine artery embolisation for the management of placenta accreta. Clin Radiol 2015; 70 (09) 932-937
39
Nieto-Calvache AJ,
Salas LF,
Duran EJ,
Benavides SO,
Ordoñez-Delgado CA,
Rodriguez-Holguin F.
Estimation of fetal radiation absorbed dose during the prophylactic use of aortic occlusion balloon for abnormally invasive placenta. J Matern Fetal Neonatal Med 2021; 34 (19) 3181-3186
40
Guan X,
Huang X,
Ye M,
Huang G,
Xiao X,
Chen J.
Treatment of placenta increta with high-intensity focused ultrasound ablation and leaving the placenta in situ: a multicenter comparative study. Front Med (Lausanne) 2022; 9: 871528
41
Palacios-Jaraquemada JM,
Fiorillo A,
Hamer J,
Martínez M,
Bruno C.
Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique. J Matern Fetal Neonatal Med 2022; 35 (02) 275-282
42
Marques ALS,
Andres MP,
Kho RM,
Abrão MS.
Is high-intensity focused ultrasound effective for the treatment of adenomyosis? a systematic review and meta-analysis. J Minim Invasive Gynecol 2020; 27 (02) 332-343
留言 (0)